Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
评估米维西安（milvexian）抑制因子XIa用于二级卒中预防的安全性和有效性（AXIOMATIC-SSP）：一项II期、国际性、随机、双盲、安慰剂对照、剂量探索性试验
期刊:Lancet Neurology
影响因子:45.5
doi:10.1016/S1474-4422(23)00403-9
Sharma, Mukul; Molina, Carlos A; Toyoda, Kazunori; Bereczki, Daniel; Bangdiwala, Shrikant I; Kasner, Scott E; Lutsep, Helmi L; Tsivgoulis, Georgios; Ntaios, George; Czlonkowska, Anna; Shuaib, Ashfaq; Amarenco, Pierre; Endres, Matthias; Yoon, Byung-Woo; Tanne, David; Toni, Danilo; Yperzeele, Laetitia; von Weitzel-Mudersbach, Paul; Sampaio Silva, Gisele; Avezum, Alvaro; Dawson, Jesse; Strbian, Daniel; Tatlisumak, Turgut; Eckstein, Jens; Ameriso, Sebastián F; Weber, Joerg R; Sandset, Else Charlotte; Goar Pogosova, Nana; Lavados, Pablo M; Arauz, Antonio; Gailani, David; Diener, Hans-Christoph; Bernstein, Richard A; Cordonnier, Charlotte; Kahl, Anja; Abelian, Grigor; Donovan, Mark; Pachai, Chahin; Li, Danshi; Hankey, Graeme J
